𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A new missense mutation (E92K) in the first transmembrane domain of the CFTR gene causes a benign cystic fibrosis phenotype

✍ Scribed by Nunes, V.; Chillón, M.; Dörk, T.; Tümmler, B.; Casals, T.; Estivill, X.

Book ID
118070459
Publisher
Oxford University Press
Year
1993
Tongue
English
Weight
398 KB
Volume
2
Category
Article
ISSN
0964-6906

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Missense mutation R1066C in the second t
Missense mutation R1066C in the second transmembrane domain of CFTR causes a severe cystic fibrosis phenotype: Study of 19 heterozygous and 2 homozygous patients
✍ T Casals; P Pacheco; C Barreto; J Giménez; MD Ramos; S Pereira; JA Pinheiro; N C 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 157 KB 👁 2 views

We report the clinical features of 21 unrelated cystic fibrosis (CF) patients from Portugal and Spain, who carry the mutation R1066C in the CFTR gene. The current age of the patients was higher in the R1066C/any mutation group (P < 0.01), as compared to the aF508/aF508 group. Poor values for lung ra

A novel missense mutation in exon 16 of
A novel missense mutation in exon 16 of the cystic fibrosis transmembrane conductance regulator (CFTR) gene identified in CBAVD patients
✍ Thierry Bienvenu; Dominique Hubert; Eric Setbon; Daniel Dusser; Jean-Claude Kapl 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 106 KB 👁 2 views

## MUTATION NOTES nucleotides downstream the original splice site in intron 3. Assuming that this would be used in the patient as donor splice site, the inclusion of 4 intronic nucleotides, frameshift, and thereby an immediate termination of translation would occur, most likely resulting in a null

A new frameshift mutation 460delG in exo
A new frameshift mutation 460delG in exon 4 of the cystic fibrosis transmembrane conductance regulator (CFTR) gene
✍ Klaus Wagner; Petra Schneditz; Walter Rosenkranz 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 112 KB 👁 2 views

The mutation described here has been detected in the DNA of a female cystic fibrosis (CF) patient born in May 1963. CF has been diagnosed only at the age of 30 years and has been confirmed by three positive sweat tests. She does not require supplementation with pancreatic enzymes and her pulmonary f